IP Library › Assignment 065100/0963
Patent Assignment
Reel/Frame 065100/0963

Assignment of Assignor's Interest

Recorded: 2023-10-02 Pages: 32
Assignors
AEGLEA BIOTHERAPEUTICS, INC.
Executed: 2023-07-27
AERASE, INC.
Executed: 2023-07-27
Assignee
IMMEDICA PHARMA AB
SOLNAVAEGEN 3H, STOCKHOLM, 113 63, SWEDEN
Covered Properties (24)
Method and Composition for Treating Arginase 1 Deficiency
Application: 62/594,747 →
Method and Composition for Treating Arginase 1 Deficiency
Application: 62/725,612 →
Method and Composition for Treating Arginase 1 Deficiency
Application: 62/745,000 →
Arginine Depletion Therapy For Treatment of GAMT Deficiency
Application: 62/747,837 →
Methods for Production of Human Recombinant Arginase 1 and Uses Thereof
Application: 62/894,319 →
Methods for Production of Human Recombinant Arginase 1 and Uses Thereof
Application: 18/338,255 →
Publication: US 2024/0110172
Treatment of Arginase 1 Deficiency
Application: 63/329,867 →
Methods For Production Of Human Recombinant Arginase 1 And Uses Thereof
Application: 17/006,383 →
Publication: US 2021/0189371
Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology Agents
Application: 62/372,092 →
Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology Agents
Application: 62/524,286 →
Method and Composition for Treating Arginase 1 Deficiency
Application: 18/344,083 →
Publication: US 2024/0009284
Use of Arginase for Treatment of Coronavirus Infection
Application: 63/005,157 →
Use of Arginase for Treatment of Coronavirus Infection
Application: 63/029,503 →
Use of Arginase for Treatment of Coronavirus Infection
Application: 63/117,025 →
Use of Arginase for Treatment of Influenza Infections
Application: 63/039,429 →
Method and Composition for Treating Arginase 1 Deficiency
Application: 16/210,248 →
Publication: US 2019/0167770
Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology Agents
Application: 15/699,951 →
Publication: US 2018/0177853
Arginine Depletion Therapy for Treatment of Gamt Deficiency
Methods for Production of Human Recombinant Arginase 1 and Uses Thereof
Treatment of Arginase 1 Deficiency
Compositions and Methos for Treating Cancer with Arginine Depletion and Immuno Oncology Agents
Method and Composition for Treating Arginase 1 Deficiency
Use of Arginase for Treatment of Coronavirus Infection
Use of Arginase for Treatment of Influenza Infections
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 13, 2018
From: LOWE, DAVID; ROWLINSON, SCOTT W.; ALTERS, SUSAN; AGNELLO, GIULIA
To: AEGLEA BIOTHERAPEUTICS, INC.
Reel/Frame 046346/0040 →
Assignment of Assignor's Interest Aug 6, 2018
From: ROWLINSON, SCOTT W.; QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 046563/0830 →
Assignment of Assignor's Interest Sep 5, 2018
From: AEGLEA BIOTHERAPEUTICS, INC.
To: AERASE, INC.
Reel/Frame 046787/0050 →
Assignment of Assignor's Interest Oct 19, 2018
From: LOWE, DAVID; ROWLINSON, SCOTT W.; ALTERS, SUSAN; AGNELLO, GIULIA
To: AEGLEA BIOTHERAPEUTICS, INC.
Reel/Frame 047235/0107 →
Assignment of Assignor's Interest Oct 23, 2018
From: AEGLEA BIOTHERAPEUTICS, INC.
To: AERASE, INC.
Reel/Frame 047270/0490 →
Assignment of Assignor's Interest Nov 14, 2018
From: QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 047498/0417 →
Assignment of Assignor's Interest Nov 27, 2018
From: ROWLINSON, SCOTT W.; QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 047591/0341 →
Assignment of Assignor's Interest Nov 27, 2018
From: ROWLINSON, SCOTT W.; QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 047591/0368 →
Assignment of Assignor's Interest Jan 10, 2019
From: ROWLINSON, SCOTT W.; QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 047956/0256 →
Assignment of Assignor's Interest Jan 10, 2019
From: ROWLINSON, SCOTT W.; QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 047956/0209 →
Assignment of Assignor's Interest Mar 8, 2022
From: ROWLINSON, SCOTT W.
To: AEGLEA BIOTHERAPEUTICS, INC.
Reel/Frame 059196/0500 →
Assignment of Assignor's Interest Jun 21, 2023
From: LOWE, DAVID; LOWE, ANN
To: AERASE, INC.
Reel/Frame 064013/0389 →
Assignment of Assignor's Interest Jun 21, 2023
From: LOWE, DAVID; LOWE, ANN
To: AERASE, INC.
Reel/Frame 064013/0540 →
Assignment of Assignor's Interest Jun 21, 2023
From: LOWE, DAVID; LOWE, ANN
To: AERASE, INC.
Reel/Frame 064013/0474 →
Assignment of Assignor's Interest Jun 21, 2023
From: LOWE, DAVID; LOWE, ANN
To: AERASE, INC.
Reel/Frame 064012/0309 →
Assignment of Assignor's Interest Jul 21, 2023
From: QUINN, ANTHONY G.
To: AEGLEA BIOTHERAPEUTICS, INC.
Reel/Frame 064335/0110 →
Assignment of Assignor's Interest Nov 21, 2023
From: ROWLINSON, SCOTT W.; QUINN, ANTHONY G.
To: AERASE, INC.
Reel/Frame 065637/0840 →
Assignment of Assignor's Interest Nov 21, 2023
From: ROWLINSON, SCOTT W.
To: AEGLEA BIOTHERAPEUTICS, INC.
Reel/Frame 065637/0719 →
Assignment of Assignor's Interest Nov 21, 2023
From: LOWE, DAVID; LOWE, ANN
To: AERASE, INC.
Reel/Frame 065637/0650 →
Assignment of Assignor's Interest Jun 4, 2024
From: QUINN, ANTHONY G.; SCHULZE, ANDREAS; ROWLINSON, SCOTT W.
To: IMMEDICA PHARMA AB.
Reel/Frame 067616/0398 →